| Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia TE Goldberg, MF Egan, T Gscheidle, R Coppola, T Weickert, ... Archives of general psychiatry 60 (9), 889-896, 2003 | 717 | 2003 |
| Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect TW Weickert, TE Goldberg, JM Gold, LB Bigelow, MF Egan, ... Archives of general psychiatry 57 (9), 907-913, 2000 | 574 | 2000 |
| Genome-wide association study identifies 30 loci associated with bipolar disorder EA Stahl, G Breen, AJ Forstner, A McQuillin, S Ripke, V Trubetskoy, ... Nature genetics 51 (5), 793-803, 2019 | 281 | 2019 |
| Anti–N‐methyl‐D‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus L Lapteva, M Nowak, CH Yarboro, K Takada, T Roebuck‐Spencer, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 242 | 2006 |
| Brain regions underlying response inhibition and interference monitoring and suppression G Blasi, TE Goldberg, T Weickert, S Das, P Kohn, B Zoltick, A Bertolino, ... European Journal of Neuroscience 23 (6), 1658-1664, 2006 | 228 | 2006 |
| Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ... Molecular Psychiatry 23 (5), 1261-1269, 2018 | 196 | 2018 |
| Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia CS Weickert, SJ Fung, VS Catts, PR Schofield, KM Allen, LT Moore, ... Molecular psychiatry 18 (11), 1185-1192, 2013 | 178 | 2013 |
| Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications TW Weickert, TE Goldberg, A Mishara, JA Apud, BS Kolachana, MF Egan, ... Biological psychiatry 56 (9), 677-682, 2004 | 162 | 2004 |
| Rethinking schizophrenia in the context of normal neurodevelopment VS Catts, SJ Fung, LE Long, D Joshi, A Vercammen, KM Allen, ... Frontiers in cellular neuroscience 7, 60, 2013 | 155 | 2013 |
| Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium TGM van Erp, E Walton, DP Hibar, L Schmaal, W Jiang, DC Glahn, ... Biological Psychiatry, 2018 | 143 | 2018 |
| Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia RW Morris, A Vercammen, R Lenroot, L Moore, JM Langton, B Short, ... Molecular Psychiatry 17 (3), 280-289, 2012 | 143 | 2012 |
| Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes BDSWG the Psychiatric Genomics Consortium Cell 173 (7), 1705-1715, 2018 | 142 | 2018 |
| Neural mechanisms underlying probabilistic category learning in normal aging F Fera, TW Weickert, TE Goldberg, A Tessitore, A Hariri, S Das, S Lee, ... Journal of Neuroscience 25 (49), 11340-11348, 2005 | 127 | 2005 |
| Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors S Jazbec, C Pantelis, T Robbins, T Weickert, DR Weinberger, ... Schizophrenia research 89 (1-3), 339-349, 2007 | 122 | 2007 |
| Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume SG Fillman, TW Weickert, RK Lenroot, SV Catts, JM Bruggemann, ... Molecular Psychiatry, 2015 | 119 | 2015 |
| Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input TW Weickert, A Terrazas, LB Bigelow, JD Malley, T Hyde, MF Egan, ... Learning & Memory 9 (6), 430-442, 2002 | 107 | 2002 |
| Transcranial direct current stimulation influences probabilistic association learning in schizophrenia A Vercammen, JA Rushby, C Loo, B Short, CS Weickert, TW Weickert Schizophrenia research 131 (1-3), 198-205, 2011 | 104 | 2011 |
| Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia TW Weickert, D Weinberg, R Lenroot, SV Catts, R Wells, A Vercammen, ... Molecular Psychiatry 20 (6), 685-694, 2015 | 100 | 2015 |
| Biomarkers in schizophrenia: a brief conceptual consideration CS Weickert, TW Weickert, A Pillai, PF Buckley Disease markers 35 (1), 3, 2013 | 91 | 2013 |
| Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds TW Weickert, TE Goldberg, S Marenco, LB Bigelow, MF Egan, ... Neuropsychopharmacology 28 (8), 1491-1500, 2003 | 87 | 2003 |
Cyndi Shannon WeickertUniversity of New South WalesVerified email at neura.edu.au
